HLA-B*57:01 allele prevalence in treatment-Naïve HIV-infected patients from Colombia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
HLA-B*57:01 allele prevalence in treatment-Naïve HIV-infected patients from Colombia ; volume:19 ; number:1 ; day:9 ; month:9 ; year:2019 ; pages:1-8 ; date:12.2019
BMC infectious diseases ; 19, Heft 1 (9.9.2019), 1-8, 12.2019
- Creator
-
Martínez Buitrago, Ernesto
Oñate, José Millán
García-Goez, José Fernando
Álvarez, Jorge
Lenis, William
Sañudo, Luz Marina
Rubiano, Luisa Consuelo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12879-019-4415-3
- URN
-
urn:nbn:de:101:1-2020012422364689311836
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Martínez Buitrago, Ernesto
- Oñate, José Millán
- García-Goez, José Fernando
- Álvarez, Jorge
- Lenis, William
- Sañudo, Luz Marina
- Rubiano, Luisa Consuelo
- SpringerLink (Online service)
Other Objects (12)
HLA-B*5701 Allele in HIV-infected Indian Children and its Association with Abacavir Hypersensitivity
Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong – a single center study
Combination antiretroviral therapy improves cognitive performance and functional connectivity in treatment-naïve HIV-infected individuals
HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects
Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study
Efficacy and safety of TMC278 in treatment-naïve, HIV-infected patients: week 96 data from TMC278-C204
Correction to: Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study
Immune and virologic responses to Truvada or Combivir as a first-line therapy of HIV-infected, treatment-naïve patients
Response of treatment-naive brain metastases to stereotactic radiosurgery
Incidence and risk factors of antiretroviral treatment failure in treatment-naïve HIV-infected patients at Chiang Mai University Hospital, Thailand
5701
Durability of pneumatic dilation monotherapy in treatment-naive achalasia patients
HLA-B*5701 Allele in HIV-infected Indian Children and its Association with Abacavir Hypersensitivity
Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong – a single center study
Combination antiretroviral therapy improves cognitive performance and functional connectivity in treatment-naïve HIV-infected individuals
HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects
Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study
Efficacy and safety of TMC278 in treatment-naïve, HIV-infected patients: week 96 data from TMC278-C204
Correction to: Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study
Immune and virologic responses to Truvada or Combivir as a first-line therapy of HIV-infected, treatment-naïve patients
Response of treatment-naive brain metastases to stereotactic radiosurgery
Incidence and risk factors of antiretroviral treatment failure in treatment-naïve HIV-infected patients at Chiang Mai University Hospital, Thailand
5701
Durability of pneumatic dilation monotherapy in treatment-naive achalasia patients
HLA-B*5701 Allele in HIV-infected Indian Children and its Association with Abacavir Hypersensitivity
Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong – a single center study
Combination antiretroviral therapy improves cognitive performance and functional connectivity in treatment-naïve HIV-infected individuals
HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects
Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study
Efficacy and safety of TMC278 in treatment-naïve, HIV-infected patients: week 96 data from TMC278-C204
Correction to: Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study
Immune and virologic responses to Truvada or Combivir as a first-line therapy of HIV-infected, treatment-naïve patients
Response of treatment-naive brain metastases to stereotactic radiosurgery
Incidence and risk factors of antiretroviral treatment failure in treatment-naïve HIV-infected patients at Chiang Mai University Hospital, Thailand
5701